Reduced tumor burden through increased oxidative stress in lung adenocarcinoma cells of PARP-1 and PARP-2 knockout mice

Biochimie

Volumn 121, Issue , 2016, Pages 278-286

  Mateu Jiménez, Mercè ^a,b   Cucarull Martínez, Blanca ^a   Yelamos, Jose ^c,d   Barreiro, Esther ^a,b  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Apoptosis; Autophagy; Lung adenocarcinoma tumors; Parp 1 and Parp 2 mice; Redox imbalance; Tumor proliferation

Indexed keywords

CATALASE; MICRORNA 223; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; TRANSCRIPTION FACTOR NFAT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, MOUSE; PARP2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER GROWTH; CONTROLLED STUDY; ENZYME INHIBITION; LUNG ADENOCARCINOMA; LUNG WEIGHT; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; TUMOR VOLUME; WEIGHT GAIN; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; FEMALE; GENETICS; KNOCKOUT MOUSE; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; FEMALE; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OXIDATIVE STRESS; POLY (ADP-RIBOSE) POLYMERASE-1; POLY(ADP-RIBOSE) POLYMERASES; TUMOR BURDEN;

EID: 84952700553     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2015.11.030     Document Type: Article

References (70)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
2. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics CA Cancer J. Clin. 64 2014 9 29
3. J. Ellis The impact of lung cancer on patients and carers Chron. Respir. Dis. 9 2012 39 47
4. C. Reddy, D. Chilla, and J. Boltax Lung cancer screening: a review of available data and current guidelines Hosp. Pract. (1995) 39 2011 107 112
5. A.J. Alberg, J.G. Ford, and J.M. Samet Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 2007 29S 55S
6. A.J. Alberg, M.V. Brock, J.G. Ford, J.M. Samet, and S.D. Spivack Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 143 2013 e1S-29S
7. G.J. Freixinet, and P.M. Rodriguez Suarez Morbidity, mortality and survival after surgery for lung cancer Arch. Bronconeumol. 51 2015 211 212
8. E. Monso, L.M. Montuenga, C.J. Sanchez de, and C. Villena Lung Cancer CIBERES-RTICC-SEPAR-Plataforma Biobanco Pulmonar, Biological Marker Analysis as Part of the CIBERES-RTIC Cancer-SEPAR Strategic Project on Lung Cancer Arch. Bronconeumol 51 9 2015 sep 462 467
9. P. Sanchez-Salcedo, J. Berto, J.P. de-Torres, A. Campo, A.B. Alcaide, G. Bastarrika, J.C. Pueyo, A. Villanueva, J.I. Echeveste, M.D. Lozano, M.J. Garcia-Velloso, L.M. Seijo, J. Garcia, W. Torre, M.J. Pajares, R. Pio, L.M. Montuenga, and J.J. Zulueta Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP) Arch. Bronconeumol. 51 2015 169 176
10. M. Rodriguez, M.T. Gomez Hernandez, N.M. Novoa, J.L. Aranda, M.F. Jimenez, and G. Varela Poorer survival in stage IB lung cancer patients after pneumonectomy Arch. Bronconeumol. 51 2015 223 226
11. A. Burkle, and L. Virag Poly(ADP-ribose): PARadigms and PARadoxes Mol. Asp. Med. 34 2013 1046 1065
12. J. Yelamos, J. Farres, L. Llacuna, C. Ampurdanes, and J. Martin-Caballero PARP-1 and PARP-2: new players in tumour development Am. J. Cancer Res. 1 2011 328 346
13. J. Yelamos, V. Schreiber, and F. Dantzer Toward specific functions of poly(ADP-ribose) polymerase-2 Trends Mol. Med. 14 2008 169 178
14. J.I. Diaz-Hernandez, S. Moncada, J.P. Bolanos, and A. Almeida Poly(ADP-ribose) polymerase-1 protects neurons against apoptosis induced by oxidative stress Cell Death. Differ. 14 2007 1211 1221
15. X. Luo, and W.L. Kraus On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1 Genes Dev. 26 2012 417 432
16. S.W. Yu, S.A. Andrabi, H. Wang, N.S. Kim, G.G. Poirier, T.M. Dawson, and V.L. Dawson Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death Proc. Natl. Acad. Sci. U. S. A. 103 2006 18314 18319
17. H.C. Ha, and S.H. Snyder Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion Proc. Natl. Acad. Sci. U. S. A. 96 1999 13978 13982
18. R. Kiefmann, K. Heckel, M. Doerger, S. Schenkat, C. Kupatt, M. Stoeckelhuber, J. Wesierska-Gadek, and A.E. Goetz Role of PARP on iNOS pathway during endotoxin-induced acute lung injury Intensive Care Med. 30 2004 1421 1431
19. R. Vaschetto, J.W. Kuiper, S.R. Chiang, J.J. Haitsma, J.W. Juco, S. Uhlig, F.B. Plotz, C.F. Della, H. Zhang, and A.S. Slutsky Inhibition of poly(adenosine diphosphate-ribose) polymerase attenuates ventilator-induced lung injury Anesthesiology 108 2008 261 268
20. J. Zheng, K. Devalaraja-Narashimha, K. Singaravelu, and B.J. Padanilam Poly(ADP-ribose) polymerase-1 gene ablation protects mice from ischemic renal injury Am. J. Physiol. Ren. Physiol. 288 2005 F387 F398
21. P. De, Y. Sun, J.H. Carlson, L.S. Friedman, B.R. Leyland-Jones, and N. Dey Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness Neoplasia 16 2014 43 72
22. H. Sui, C. Shi, Z. Yan, and H. Li Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy Drug Des. Devel. Ther. 9 2015 3183 3190
23. K.S. Tewari, R.N. Eskander, and B.J. Monk Development of olaparib for BRCA-deficient recurrent epithelial ovarian cancer Clin. Cancer Res. 2015
24. R. van der Noll, S. Marchetti, N. Steeghs, J.H. Beijnen, M.W. Mergui-Roelvink, E. Harms, H. Rehorst, G.S. Sonke, and J.H. Schellens Long-term safety and anti-tumour activity of olaparib monotherapy after combination with carboplatin and paclitaxel in patients with advanced breast, ovarian or fallopian tube cancer Br. J. Cancer 2015
25. M.J. Schiewer, J.F. Goodwin, S. Han, J.C. Brenner, M.A. Augello, J.L. Dean, F. Liu, J.L. Planck, P. Ravindranathan, A.M. Chinnaiyan, P. McCue, L.G. Gomella, G.V. Raj, A.P. Dicker, J.R. Brody, J.M. Pascal, M.M. Centenera, L.M. Butler, W.D. Tilley, F.Y. Feng, and K.E. Knudsen Dual roles of PARP-1 promote cancer growth and progression Cancer Discov. 2 2012 1134 1149
26. F. Rojo, J. Garcia-Parra, S. Zazo, I. Tusquets, J. Ferrer-Lozano, S. Menendez, P. Eroles, C. Chamizo, S. Servitja, N. Ramirez-Merino, F. Lobo, B. Bellosillo, J.M. Corominas, J. Yelamos, S. Serrano, A. Lluch, A. Rovira, and J. Albanell Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer Ann. Oncol. 23 2012 1156 1164
27. D. Davar, J.H. Beumer, L. Hamieh, and H. Tawbi Role of PARP inhibitors in cancer biology and therapy Curr. Med. Chem. 19 2012 3907 3921
28. P. Domagala, T. Huzarski, J. Lubinski, K. Gugala, and W. Domagala PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy Breast Cancer Res. Treat. 127 2011 861 869
29. J.M. Lee, J.A. Ledermann, and E.C. Kohn PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies Ann. Oncol. 25 2014 32 40
30. Y.R. Lee, D.S. Yu, Y.C. Liang, K.F. Huang, S.J. Chou, T.C. Chen, C.C. Lee, C.L. Chen, S.H. Chiou, and H.S. Huang New approaches of PARP-1 inhibitors in human lung cancer cells and cancer stem-like cells by some selected anthraquinone-derived small molecules PLoS One 8 2013 e56284
31. S. Postel-Vinay, I. Bajrami, L. Friboulet, R. Elliott, Y. Fontebasso, N. Dorvault, K.A. Olaussen, F. Andre, J.C. Soria, C.J. Lord, and A. Ashworth A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer Oncogene 32 2013 5377 5387
32. M. Rouleau, A. Patel, M.J. Hendzel, S.H. Kaufmann, and G.G. Poirier PARP inhibition: PARP1 and beyond Nat. Rev. Cancer 10 2010 293 301
33. E. Barreiro, D. Sanchez, J.B. Galdiz, S.N. Hussain, and J. Gea N-acetylcysteine increases manganese superoxide dismutase activity in septic rat diaphragms Eur. Respir. J. 26 2005 1032 1039
34. E. Barreiro, V.I. Peinado, J.B. Galdiz, E. Ferrer, J. Marin-Corral, F. Sanchez, J. Gea, and J.A. Barbera Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction Am. J. Respir. Crit. Care Med. 182 2010 477 488
35. E. Barreiro, C. Fermoselle, M. Mateu-Jimenez, A. Sanchez-Font, L. Pijuan, J. Gea, and V. Curull Oxidative stress and inflammation in the normal airways and blood of patients with lung cancer and COPD Free Radic. Biol. Med. 65 2013 859 871
36. A. Chacon-Cabrera, C. Fermoselle, A.J. Urtreger, M. Mateu-Jimenez, M.J. Diament, E.D. de Kier Joffe, M. Sandri, and E. Barreiro Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness J. Cell Physiol. 229 2014 1660 1672
37. A. Gupta, S. Srivastava, R. Prasad, S.M. Natu, B. Mittal, M.P. Negi, and A.N. Srivastava Oxidative stress in non-small cell lung cancer patients after chemotherapy: association with treatment response Respirology 15 2010 349 356
38. G. Filomeni, Z.D. De, and F. Cecconi Oxidative stress and autophagy: the clash between damage and metabolic needs Cell Death. Differ. 22 2015 377 388
39. J.J. Jaboin, M. Hwang, and B. Lu Autophagy in lung cancer Methods Enzymol. 453 2009 287 304
40. M.M. Pore, T.J. Hiltermann, and F.A. Kruyt Targeting apoptosis pathways in lung cancer Cancer Lett. 332 2013 359 368
41. B. Catalgol, B. Wendt, S. Grimm, N. Breusing, N.K. Ozer, and T. Grune Chromatin repair after oxidative stress: role of PARP-mediated proteasome activation Free Radic. Biol. Med. 48 2010 673 680
42. M.M. Streppel, S. Pai, N.R. Campbell, C. Hu, S. Yabuuchi, M.I. Canto, J.S. Wang, E.A. Montgomery, and A. Maitra MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1 Clin. Cancer Res. 19 2013 4067 4078
43. J. Meloche, G.M. Le, F. Potus, J. Vinck, B. Ranchoux, I. Johnson, F. Antigny, E. Tremblay, S. Breuils-Bonnet, F. Perros, S. Provencher, and S. Bonnet miR-223 reverses experimental pulmonary arterial hypertension Am. J. Physiol. Cell Physiol. 309 2015 C363 C372
44. S.A. Andrabi, N.S. Kim, S.W. Yu, H. Wang, D.W. Koh, M. Sasaki, J.A. Klaus, T. Otsuka, Z. Zhang, R.C. Koehler, P.D. Hurn, G.G. Poirier, V.L. Dawson, and T.M. Dawson Poly(ADP-ribose) (PAR) polymer is a death signal Proc. Natl. Acad. Sci. U. S. A. 103 2006 18308 18313
45. S.W. Yu, H. Wang, M.F. Poitras, C. Coombs, W.J. Bowers, H.J. Federoff, G.G. Poirier, T.M. Dawson, and V.L. Dawson Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor Science 297 2002 259 263
46. J.A. Munoz-Gamez, J.M. Rodriguez-Vargas, R. Quiles-Perez, R. Aguilar-Quesada, D. Martin-Oliva, M.G. de, M.J. Menissier de, A. Almendros, A.M. Ruiz de, and F.J. Oliver PARP-1 is involved in autophagy induced by DNA damage Autophagy 5 2009 61 74
47. J.M. Rodriguez-Vargas, M.J. Ruiz-Magana, C. Ruiz-Ruiz, J. Majuelos-Melguizo, A. Peralta-Leal, M.I. Rodriguez, J.A. Munoz-Gamez, M.R. de Almodovar, E. Siles, A.L. Rivas, M. Jaattela, and F.J. Oliver ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy Cell Res. 22 2012 1181 1198
48. A. Chacon-Cabrera, C. Fermoselle, I. Salmela, J. Yelamos, and E. Barreiro MicroRNA expression and protein acetylation pattern in respiratory and limb muscles of Parp-1(-/-) and Parp-2(-/-) mice with lung cancer cachexia Biochim. Biophys. Acta 1850 2015 2530 2543
49. D. Tarin Role of the host stroma in cancer and its therapeutic significance Cancer Metastasis Rev. 32 2013 553 566
50. M.J. Diament, C. Garcia, I. Stillitani, V.M. Saavedra, T. Manzur, L. Vauthay, and S. Klein Spontaneous murine lung adenocarcinoma (P07): A new experimental model to study paraneoplastic syndromes of lung cancer Int. J. Mol. Med. 2 1998 45 50
51. J.M. de Murcia, C. Niedergang, C. Trucco, M. Ricoul, B. Dutrillaux, M. Mark, F.J. Oliver, M. Masson, A. Dierich, M. LeMeur, C. Walztinger, and P. Chambon M. G. de, Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells Proc. Natl. Acad. Sci. U. S. A. 94 1997 7303 7307
52. J. Corral, J. Yelamos, D. Hernandez-Espinosa, Y. Monreal, R. Mota, I. Arcas, A. Minano, P. Parrilla, and V. Vicente Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models Am. J. Pathol. 166 2005 1089 1098
53. C. Fermoselle, R. Rabinovich, P. Ausin, E. Puig-Vilanova, C. Coronell, F. Sanchez, J. Roca, J. Gea, and E. Barreiro Does oxidative stress modulate limb muscle atrophy in severe COPD patients? Eur. Respir. J. 40 2012 851 862
54. J.M. Albert, C. Cao, K.W. Kim, C.D. Willey, L. Geng, D. Xiao, H. Wang, A. Sandler, D.H. Johnson, A.D. Colevas, J. Low, M.L. Rothenberg, and B. Lu Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models Clin. Cancer Res. 13 2007 3033 3042
55. J.M. Senra, B.A. Telfer, K.E. Cherry, C.M. McCrudden, D.G. Hirst, M.J. O'Connor, S.R. Wedge, and I.J. Stratford Inhibition of PARP-1 by olaparib (AZD2281) increases the radiosensitivity of a lung tumor xenograft Mol. Cancer Ther. 10 2011 1949 1958
56. H. Sui, C. Shi, Z. Yan, and H. Li Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy Drug Des. Devel. Ther. 9 2015 3183 3190
57. A. Miar, D. Hevia, H. Munoz-Cimadevilla, A. Astudillo, J. Velasco, R.M. Sainz, and J.C. Mayo Manganese superoxide dismutase (SOD2/MnSOD)/catalase and SOD2/GPx1 ratios as biomarkers for tumor progression and metastasis in prostate, colon, and lung cancer Free Radic. Biol. Med. 85 2015 45 55
58. T. Kalai, M. Balog, A. Szabo, G. Gulyas, J. Jeko, B. Sumegi, and K. Hideg New poly(ADP-ribose) polymerase-1 inhibitors with antioxidant activity based on 4-carboxamidobenzimidazole-2-ylpyrroline and -tetrahydropyridine nitroxides and their precursors J. Med. Chem. 52 2009 1619 1629
59. S.W. Suh, A.M. Hamby, E.T. Gum, B.S. Shin, S.J. Won, C.T. Sheline, P.H. Chan, and R.A. Swanson Sequential release of nitric oxide, zinc, and superoxide in hypoglycemic neuronal death J. Cereb. Blood Flow. Metab. 28 2008 1697 1706
60. P. Wyrsch, C. Blenn, J. Bader, and F.R. Althaus Cell death and autophagy under oxidative stress: roles of poly(ADP-Ribose) polymerases and Ca(2+) Mol. Cell Biol. 32 2012 3541 3553
61. N.N. Gangopadhyay, J.D. Luketich, A. Opest, C. Visus, E.M. Meyer, R. Landreneau, and M.J. Schuchert Inhibition of poly(ADP-ribose) polymerase (PARP) induces apoptosis in lung cancer cell lines Cancer Investig. 29 2011 608 616
62. G. Karpel-Massler, F. Pareja, P. Aime, C. Shu, L. Chau, M.A. Westhoff, M.E. Halatsch, J.F. Crary, P. Canoll, and M.D. Siegelin PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma PLoS One 9 2014 e114583
63. T.J. Gaymes, S. Shall, L.J. MacPherson, N.A. Twine, N.C. Lea, F. Farzaneh, and G.J. Mufti Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes Haematologica 94 2009 638 646
64. C. Ethier, Y. Labelle, and G.G. Poirier PARP-1-induced cell death through inhibition of the MEK/ERK pathway in MNNG-treated HeLa cells Apoptosis 12 2007 2037 2049
65. R. Huang, Y. Xu, W. Wan, X. Shou, J. Qian, Z. You, B. Liu, C. Chang, T. Zhou, J. Lippincott-Schwartz, and W. Liu Deacetylation of nuclear LC3 drives autophagy initiation under starvation Mol. Cell 57 2015 456 466
66. A. Luna, M.I. Aladjem, and K.W. Kohn SIRT1/PARP1 crosstalk: connecting DNA damage and metabolism Genome Integr. 4 2013 6
67. J.W. Hwang, S. Chung, I.K. Sundar, H. Yao, G. Arunachalam, M.W. McBurney, and I. Rahman Cigarette smoke-induced autophagy is regulated by SIRT1-PARP-1-dependent mechanism: implication in pathogenesis of COPD Arch. Biochem. Biophys. 500 2010 203 209
68. P. Bai, C. Canto, H. Oudart, A. Brunyanszki, Y. Cen, C. Thomas, H. Yamamoto, A. Huber, B. Kiss, R.H. Houtkooper, K. Schoonjans, V. Schreiber, A.A. Sauve, M.J. Menissier-de, and J. Auwerx PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation Cell Metab. 13 2011 461 468
69. P. Bai, C. Canto, A. Brunyanszki, A. Huber, M. Szanto, Y. Cen, H. Yamamoto, S.M. Houten, B. Kiss, H. Oudart, P. Gergely, M.J. Menissier-de, V. Schreiber, A.A. Sauve, and J. Auwerx PARP-2 regulates SIRT1 expression and whole-body energy expenditure Cell Metab. 13 2011 450 460
70. J. Meloche, A. Pflieger, M. Vaillancourt, R. Paulin, F. Potus, S. Zervopoulos, C. Graydon, A. Courboulin, S. Breuils-Bonnet, E. Tremblay, C. Couture, E.D. Michelakis, S. Provencher, and S. Bonnet Role for DNA damage signaling in pulmonary arterial hypertension Circulation 129 2014 786 797